Evaluating the prevalence and severity of metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus in primary care.

Balkhed W, Bergram M, Iredahl F, Holmberg M, Edin C, Carlhäll CJ, Ebbers T, Henriksson P, Simonsson C, Rådholm K, Cedersund G, Forsgren M, Leinhard OD, Jönsson C, Lundberg P, Kechagias S, Dahlström N, Nasr P, Ekstedt M

Open source

DOI
10.1111/joim.20103
Published
2025 Sep
Container
Journal of internal medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/joim.20103,
  title = {Evaluating the prevalence and severity of metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus in primary care.},
  author = {Balkhed W and Bergram M and Iredahl F and Holmberg M and Edin C and Carlhäll CJ and Ebbers T and Henriksson P and Simonsson C and Rådholm K and Cedersund G and Forsgren M and Leinhard OD and Jönsson C and Lundberg P and Kechagias S and Dahlström N and Nasr P and Ekstedt M},
  year = {2025},
  journal = {Journal of internal medicine},
  doi = {10.1111/joim.20103},
  url = {https://doi.org/10.1111/joim.20103}
}

RIS

TY  - JOUR
TI  - Evaluating the prevalence and severity of metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus in primary care.
AU  - Balkhed W
AU  - Bergram M
AU  - Iredahl F
AU  - Holmberg M
AU  - Edin C
AU  - Carlhäll CJ
AU  - Ebbers T
AU  - Henriksson P
AU  - Simonsson C
AU  - Rådholm K
AU  - Cedersund G
AU  - Forsgren M
AU  - Leinhard OD
AU  - Jönsson C
AU  - Lundberg P
AU  - Kechagias S
AU  - Dahlström N
AU  - Nasr P
AU  - Ekstedt M
PY  - 2025
JO  - Journal of internal medicine
DO  - 10.1111/joim.20103
UR  - https://doi.org/10.1111/joim.20103
ER  - 

APA

W, B., M, B., F, I., M, H., C, E., CJ, C., T, E., P, H., C, S., K, R., G, C., M, F., OD, L., C, J., P, L., S, K., N, D., P, N., & M, E. (2025). Evaluating the prevalence and severity of metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus in primary care.. Journal of internal medicine. https://doi.org/10.1111/joim.20103

Source records